The Impact of the NIS2 Directive and the CER Directive for Medical Device Manufacturers and the Healthcare Sector

The rise in the volume of cyber incidents, the war in Ukraine, and the recent pandemic, has increased focus on the risks for medical device manufacturers and healthcare providers inherent in the data they collect and hold, including the risks posed by the ongoing threat of cyber-attacks. This is where the NIS2 Directive and the CER Directive come in.

In this article we will consider the Network and Information Systems Directive (EU) 2022/0383 (“NIS2”) and the Directive on the Resilience of Critical Entities (EU) 2022/2557 (“CER Directive”) and the impact that they will have on medical device manufacturers and healthcare providers.

Read the full article here

Latest insights

More Insights
City skyline at dusk

Five Key Considerations for M&A in the Retail and Consumer Sector

Jun 28 2024

Read More
Curiosity line blue background

Are you ready for Hong Kong’s Cybersecurity law?

Jun 28 2024

Read More
Snow-capped mountain range

Economic Crime and Corporate Transparency Act 2023 – Implications of the UK Act for Australian companies

Jun 28 2024

Read More